PainWeek 2013

Studies Document Long-Term Benefits of Transdermal Buprenorphine

Patients with moderate-to-severe chronic low-back pain and osteoarthritis who had significant gains in quality of life, sleep quality, functioning, and work productivity during 12-week core trials of continuous treatment with buprenorphine transdermal delivery system (Butrans) had these benefits maintained long-term, according to a posthoc analysis reported Rupa Shah, PharmD, and colleagues at PAINWeek 2013.

Project ECHO Brings Pain Expertise to Rural Docs

Project ECHO Chronic Pain Program is co-directed by Joanna G. Katzman, MD, a neurologist, and George D. Comerci, Jr., MD. Dr. Katzman, Director of the UNM Pain Center, spearheaded creation of the program “as a way to leverage scarce pain resources for primary care providers working in rural and underserved areas” where their patients had to wait many months for a specialty pain consultation.